
GLP-1 weight-loss medications linked to improved cancer survival in certain patients
Fox News
New study shows colon cancer patients taking GLP-1 drugs like Ozempic had 15% mortality vs. 37% for non-users over five years, suggesting significant survival benefits.
Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
They found that the patients were much less likely to die within five years than those who weren’t taking the drugs.
More Related News

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












